Skip to main content

Advertisement

SpringerLink
Log in

Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

In 2009, the European Centre for Disease Prevention and Control (ECDC) estimated that multidrug-resistant (MDR) bacterial infections were responsible for 25,000 extra-deaths per year. In 2015, another report estimated that 12,500 extra-deaths were attributable to MDR bacteria every year in France. Recently, the United Nations claimed that resistance to antimicrobials was a global scourge, forecasting 10 million deaths in 2050. Surprisingly, our antibiotic resistance surveillance system in Marseille, France, did not allowed us to observe similar trends. We herein compared our data on extremely drug-resistant (XDR)/pandrug-resistant (PDR) patient extra-deaths to evaluations and predictions from these reports. First, we retrospectively collect and analyze antibiotic resistance data produced by our settings between November 2009 and March 2015 to look for 30-day deaths attributable to XDR/PDR strains belonging to 11 bacterial species/genus. In parallel, we performed a PubMed literature search to look for articles published prior to July 2016 and describing human deaths due to PDR strains. Overall, 35,723 patients were infected by at least one bacterial species/genus of interest and 85 by XDR/PDR strains. Of these patients, only one death was attributable to a XDR bacterial infection in a patient with strong comorbidities and two consecutive septic shocks. Our literature review shows that only four articles described human deaths due to PDR bacteria. All together, these data allowed us to conclude that there is a large discrepancy between the real count of deaths attributable to XDR/PDR bacteria and alarmist predictions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. ECDC/EMEA Joint Technical Report (2009) The bacterial challenge: time to react. 2009. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed 17 May 2018

  2. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P et al (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9:894–896

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. World Health Organization (2014) Antimicrobial resistance: global report on surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf. Accessed 17 May 2018

  4. Colomb-Cotinat M, Lacoste J, Coignard B, Vaux S (2015) Morbidité et mortalité des infections à bactéries multi-résistantes aux antibiotiques en France en 2012. http://invs.santepubliquefrance.fr/content/download/116892/409658/version/1/file/Rapport_DMI_RATB_Burden_BAT.pdf. Accessed 17 May 2018

  5. O’Neill J (2014) Antimicrobial resistance: tackling a crisis for the health and wealth of nations. https://amr-review.org/sites/default/files/AMR Review Paper - Tackling a crisis for the health and wealth of nations_1.pdf. Accessed 17 May 2018

  6. Abat C, Chaudet H, Colson P, Rolain J-M, Raoult D (2015) Real-time microbiology laboratory surveillance system to detect abnormal events and emerging infections, Marseille, France. Emerg Infect Dis 21:1302–1310

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A et al (2004) The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 56:277–282

    Article  PubMed  CAS  Google Scholar 

  8. Hadjiliadis D, Steele MP, Chaparro C, Singer LG, Waddell TK, Hutcheon MA et al (2007) Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 26:834–838

    Article  PubMed  Google Scholar 

  9. Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A (2008) Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 32:450–454

    Article  PubMed  CAS  Google Scholar 

  10. Elemam A, Rahimian J, Mandell W (2009) Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis 49:271–274

    Article  PubMed  Google Scholar 

  11. Rolain J-M, Abat C, Jimeno M-T, Fournier P-E, Raoult D (2016) Do we need new antibiotics? Clin Microbiol Infect 22:408–415

    Article  PubMed  Google Scholar 

  12. Ramírez-Estrada S, Borgatta B, Rello J (2016) Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect Drug Resist 9:7–18

    PubMed  PubMed Central  Google Scholar 

  13. Bodey GP, Jadeja L, Elting L (1985) Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145:1621–1629

    Article  PubMed  CAS  Google Scholar 

  14. Recio R, Villa J, Viedma E, Ángeles Orellana M, Lora-Tamayo J, Chaves F (2018) Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: facing the perfect storm. Int J Antimicrob Agents In press https://doi.org/10.1016/j.ijantimicag.2018.03.018

  15. ECDC. Antimicrobial resistance surveillance in Europe 2016 (2017) Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). https://ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf. Accessed 17 May 2018

  16. Abat C, Rolain J-M, Dubourg G, Fournier P-E, Chaudet H, Raoult D (2017) Evaluating the clinical burden and mortality attributable to antibiotic resistance: the disparity of empirical data and simple model estimations. Clin Infect Dis 65:S58–S63

    Article  PubMed  Google Scholar 

  17. de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 29(13):e1002184

    Article  Google Scholar 

  18. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ (2014) Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20:1170–1175

    Article  PubMed  PubMed Central  Google Scholar 

  19. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8:260–271

    Article  PubMed  CAS  Google Scholar 

  20. Moran NA (2002) Microbial minimalism: genome reduction in bacterial pathogens. Cell 8(108):583–586

    Article  Google Scholar 

  21. López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M et al (2011) Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203:545–548

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hraiech S, Roch A, Lepidi H, Atieh T, Audoly G, Rolain J-M et al (2013) Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia. Antimicrob Agents Chemother 57:5120–5121

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Levy Hara G, Kanj SS, Pagani L, Abbo L, Endimiani A, Wertheim HFL et al (2016) Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy. Int J Antimicrob Agents 48:239–246

    Article  PubMed  CAS  Google Scholar 

  24. Pulcini C, Mainardi J-L (2014) Antimicrobial stewardship: an international emergency. Clin Microbiol Infect 20:947–948

    Article  PubMed  CAS  Google Scholar 

  25. Brouqui P, Jouve E, Romain F, Sambuc R, Raoult D (2014) Are infectious disease doctors better at caring for infectious diseases than other specialists? Clin Infect Dis 58:1486–1487

    Article  PubMed  Google Scholar 

  26. Brouqui P, Boudjema S, Soto Aladro A, Chabrière E, Florea O, Nguyen H et al (2017) New approaches to prevent healthcare-associated infection. Clin Infect Dis 65:S50–S54

    Article  PubMed  Google Scholar 

  27. Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12–S19

    Article  PubMed  Google Scholar 

  28. Lagier JC, Million M, Fournier PE, Brouqui P, Raoult D (2015) Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae. J Hosp Infect 90:173–174

    Article  PubMed  CAS  Google Scholar 

  29. Brouqui P, Aubry C, Million M, Drancourt M, Raoult D (2013) Totally resistant tuberculosis: will antileprosy drugs be helpful? Int J Antimicrob Agents 42:584–585

    Article  PubMed  CAS  Google Scholar 

  30. Pulcini C, Mohrs S, Beovic B, Gyssens I, Theuretzbacher U, Cars O et al (2017) Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia. Int J Antimicrob Agents 49:98–101

    Article  PubMed  CAS  Google Scholar 

  31. Dubourg G, Okdah L, Le Page S, Rolain J-M, Raoult D (2015) In vitro activity of “old antibiotics” against highly resistant Gram-negative bacteria. Int J Antimicrob Agents 46:718–720

    Article  PubMed  CAS  Google Scholar 

  32. Abat C, Raoult D, Rolain J-M (2018) Are we living in an antibiotic resistance nightmare? Clin Microbiol Infect XXX:1–2

    Google Scholar 

  33. McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R et al (2016) Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 60:4420–4421

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IRD, MEPHI, AP-HM, IHU-Méditerranée-Infection, Aix-Marseille University, Marseille, France

    Cédric Abat, Jean-Marc Rolain & Didier Raoult

  2. IRD, VITROME, AP-HM, SSA, IHU-Méditerranée-Infection, Aix-Marseille University, Marseille, France

    Pierre-Edouard Fournier & Marie-Thérèse Jimeno

  3. URMITE, UMR CNRS 7278, IRD 198, INSERM U1095, Faculté de Médecine, 27 boulevard Jean Moulin, 13385, Marseille CEDEX 5, France

    Jean-Marc Rolain & Didier Raoult

Authors
  1. Cédric Abat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre-Edouard Fournier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marie-Thérèse Jimeno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Marc Rolain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Didier Raoult
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jean-Marc Rolain or Didier Raoult.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study formal consent is not required.

Informed consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abat, C., Fournier, PE., Jimeno, MT. et al. Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?. Eur J Clin Microbiol Infect Dis 37, 1687–1697 (2018). https://doi.org/10.1007/s10096-018-3300-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-018-3300-0

Keywords

Search

Navigation